Literature DB >> 30046110

53BP1 cooperation with the REV7-shieldin complex underpins DNA structure-specific NHEJ.

Hind Ghezraoui1, Catarina Oliveira1, Jordan R Becker1, Kirstin Bilham1, Daniela Moralli2, Consuelo Anzilotti3, Roman Fischer4, Mukta Deobagkar-Lele3, Maria Sanchiz-Calvo1, Elena Fueyo-Marcos1, Sarah Bonham4, Benedikt M Kessler4, Sven Rottenberg5, Richard J Cornall3, Catherine M Green2, J Ross Chapman6.   

Abstract

53BP1 governs a specialized, context-specific branch of the classical non-homologous end joining DNA double-strand break repair pathway. Mice lacking 53bp1 (also known as Trp53bp1) are immunodeficient owing to a complete loss of immunoglobulin class-switch recombination1,2, and reduced fidelity of long-range V(D)J recombination3. The 53BP1-dependent pathway is also responsible for pathological joining events at dysfunctional telomeres4, and its unrestricted activity in Brca1-deficient cellular and tumour models causes genomic instability and oncogenesis5-7. Cells that lack core non-homologous end joining proteins are profoundly radiosensitive8, unlike 53BP1-deficient cells9,10, which suggests that 53BP1 and its co-factors act on specific DNA substrates. Here we show that 53BP1 cooperates with its downstream effector protein REV7 to promote non-homologous end joining during class-switch recombination, but REV7 is not required for 53BP1-dependent V(D)J recombination. We identify shieldin-a four-subunit putative single-stranded DNA-binding complex comprising REV7, c20orf196 (SHLD1), FAM35A (SHLD2) and FLJ26957 (SHLD3)-as the factor that explains this specificity. Shieldin is essential for REV7-dependent DNA end-protection and non-homologous end joining during class-switch recombination, and supports toxic non-homologous end joining in Brca1-deficient cells, yet is dispensable for REV7-dependent interstrand cross-link repair. The 53BP1 pathway therefore comprises distinct double-strand break repair activities within chromatin and single-stranded DNA compartments, which explains both the immunological differences between 53bp1- and Rev7- deficient mice and the context specificity of the pathway.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30046110      PMCID: PMC6989217          DOI: 10.1038/s41586-018-0362-1

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  33 in total

1.  DNA damage defines sites of recurrent chromosomal translocations in B lymphocytes.

Authors:  Ofir Hakim; Wolfgang Resch; Arito Yamane; Isaac Klein; Kyong-Rim Kieffer-Kwon; Mila Jankovic; Thiago Oliveira; Anne Bothmer; Ty C Voss; Camilo Ansarah-Sobrinho; Ewy Mathe; Genqing Liang; Jesse Cobell; Hirotaka Nakahashi; Davide F Robbiani; Andre Nussenzweig; Gordon L Hager; Michel C Nussenzweig; Rafael Casellas
Journal:  Nature       Date:  2012-02-07       Impact factor: 49.962

2.  A cell cycle-dependent regulatory circuit composed of 53BP1-RIF1 and BRCA1-CtIP controls DNA repair pathway choice.

Authors:  Cristina Escribano-Díaz; Alexandre Orthwein; Amélie Fradet-Turcotte; Mengtan Xing; Jordan T F Young; Ján Tkáč; Michael A Cook; Adam P Rosebrock; Meagan Munro; Marella D Canny; Dongyi Xu; Daniel Durocher
Journal:  Mol Cell       Date:  2013-01-17       Impact factor: 17.970

3.  Crystal structure of human REV7 in complex with a human REV3 fragment and structural implication of the interaction between DNA polymerase zeta and REV1.

Authors:  Kodai Hara; Hiroshi Hashimoto; Yoshiki Murakumo; Shunsuke Kobayashi; Toshiaki Kogame; Satoru Unzai; Satoko Akashi; Shunichi Takeda; Toshiyuki Shimizu; Mamoru Sato
Journal:  J Biol Chem       Date:  2010-02-17       Impact factor: 5.157

4.  A selective requirement for 53BP1 in the biological response to genomic instability induced by Brca1 deficiency.

Authors:  Liu Cao; Xioaling Xu; Samuel F Bunting; Jie Liu; Rui-Hong Wang; Longyue L Cao; J Julie Wu; Tie-Nan Peng; Junjie Chen; Andre Nussenzweig; Chu-Xia Deng; Toren Finkel
Journal:  Mol Cell       Date:  2009-08-28       Impact factor: 17.970

5.  Rif1 prevents resection of DNA breaks and promotes immunoglobulin class switching.

Authors:  Michela Di Virgilio; Elsa Callen; Arito Yamane; Wenzhu Zhang; Mila Jankovic; Alexander D Gitlin; Niklas Feldhahn; Wolfgang Resch; Thiago Y Oliveira; Brian T Chait; André Nussenzweig; Rafael Casellas; Davide F Robbiani; Michel C Nussenzweig
Journal:  Science       Date:  2013-01-10       Impact factor: 47.728

6.  Identification and characterisation of mRif1: a mouse telomere-associated protein highly expressed in germ cells and embryo-derived pluripotent stem cells.

Authors:  Ian R Adams; Anne McLaren
Journal:  Dev Dyn       Date:  2004-04       Impact factor: 3.780

7.  A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles.

Authors:  Sebastian A Wagner; Petra Beli; Brian T Weinert; Michael L Nielsen; Jürgen Cox; Matthias Mann; Chunaram Choudhary
Journal:  Mol Cell Proteomics       Date:  2011-09-01       Impact factor: 5.911

8.  The Phyre2 web portal for protein modeling, prediction and analysis.

Authors:  Lawrence A Kelley; Stefans Mezulis; Christopher M Yates; Mark N Wass; Michael J E Sternberg
Journal:  Nat Protoc       Date:  2015-05-07       Impact factor: 13.491

9.  53BP1 is required for class switch recombination.

Authors:  Irene M Ward; Bernardo Reina-San-Martin; Alexandru Olaru; Kay Minn; Koji Tamada; Julie S Lau; Marilia Cascalho; Lieping Chen; Andre Nussenzweig; Ferenc Livak; Michel C Nussenzweig; Junjie Chen
Journal:  J Cell Biol       Date:  2004-05-24       Impact factor: 10.539

10.  53BP1 Integrates DNA Repair and p53-Dependent Cell Fate Decisions via Distinct Mechanisms.

Authors:  Raquel Cuella-Martin; Catarina Oliveira; Helen E Lockstone; Suzanne Snellenberg; Natalia Grolmusova; J Ross Chapman
Journal:  Mol Cell       Date:  2016-08-18       Impact factor: 17.970

View more
  104 in total

1.  The nuclear structural protein NuMA is a negative regulator of 53BP1 in DNA double-strand break repair.

Authors:  Naike Salvador Moreno; Jing Liu; Karen M Haas; Laurie L Parker; Chaitali Chakraborty; Stephen J Kron; Kurt Hodges; Lance D Miller; Carl Langefeld; Paul J Robinson; Sophie A Lelièvre; Pierre-Alexandre Vidi
Journal:  Nucleic Acids Res       Date:  2019-04-08       Impact factor: 16.971

Review 2.  Shieldin - the protector of DNA ends.

Authors:  Dheva Setiaputra; Daniel Durocher
Journal:  EMBO Rep       Date:  2019-04-04       Impact factor: 8.807

3.  RPA Phosphorylation Inhibits DNA Resection.

Authors:  Michael M Soniat; Logan R Myler; Hung-Che Kuo; Tanya T Paull; Ilya J Finkelstein
Journal:  Mol Cell       Date:  2019-05-29       Impact factor: 17.970

4.  DYNLL1 binds to MRE11 to limit DNA end resection in BRCA1-deficient cells.

Authors:  Yizhou Joseph He; Khyati Meghani; Marie-Christine Caron; Chunyu Yang; Daryl A Ronato; Jie Bian; Anchal Sharma; Jessica Moore; Joshi Niraj; Alexandre Detappe; John G Doench; Gaelle Legube; David E Root; Alan D D'Andrea; Pascal Drané; Subhajyoti De; Panagiotis A Konstantinopoulos; Jean-Yves Masson; Dipanjan Chowdhury
Journal:  Nature       Date:  2018-10-31       Impact factor: 49.962

Review 5.  DNA double-strand break repair pathway choice - from basic biology to clinical exploitation.

Authors:  Ron D Jachimowicz; Jonas Goergens; H Christian Reinhardt
Journal:  Cell Cycle       Date:  2019-05-22       Impact factor: 4.534

Review 6.  Restored replication fork stabilization, a mechanism of PARP inhibitor resistance, can be overcome by cell cycle checkpoint inhibition.

Authors:  Brittany Haynes; Junko Murai; Jung-Min Lee
Journal:  Cancer Treat Rev       Date:  2018-09-11       Impact factor: 12.111

7.  EZH2 Inhibition Sensitizes CARM1-High, Homologous Recombination Proficient Ovarian Cancers to PARP Inhibition.

Authors:  Sergey Karakashev; Takeshi Fukumoto; Bo Zhao; Jianhuang Lin; Shuai Wu; Nail Fatkhutdinov; Pyoung-Hwa Park; Galina Semenova; Stephanie Jean; Mark G Cadungog; Mark E Borowsky; Andrew V Kossenkov; Qin Liu; Rugang Zhang
Journal:  Cancer Cell       Date:  2020-01-30       Impact factor: 31.743

8.  ASTE1 promotes shieldin-complex-mediated DNA repair by attenuating end resection.

Authors:  Fei Zhao; Wootae Kim; Huanyao Gao; Chao Liu; Yong Zhang; Yuping Chen; Min Deng; Qin Zhou; Jinzhou Huang; Qi Hu; Shih-Hsun Chen; Somaira Nowsheen; Jake A Kloeber; Bo Qin; Ping Yin; Xinyi Tu; Guijie Guo; Sisi Qin; Chao Zhang; Ming Gao; Kuntian Luo; Yilun Liu; Zhenkun Lou; Jian Yuan
Journal:  Nat Cell Biol       Date:  2021-08-05       Impact factor: 28.824

Review 9.  The molecular basis and disease relevance of non-homologous DNA end joining.

Authors:  Bailin Zhao; Eli Rothenberg; Dale A Ramsden; Michael R Lieber
Journal:  Nat Rev Mol Cell Biol       Date:  2020-10-19       Impact factor: 94.444

10.  REV7 has a dynamic adaptor region to accommodate small GTPase RAN/Shigella IpaB ligands, and its activity is regulated by the RanGTP/GDP switch.

Authors:  Xin Wang; Nomi Pernicone; Limor Pertz; Deping Hua; Tianqing Zhang; Tamar Listovsky; Wei Xie
Journal:  J Biol Chem       Date:  2019-09-04       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.